Literature DB >> 20055425

Heat shock protein 90: inhibitors in clinical trials.

Marco A Biamonte1, Ryan Van de Water, Joseph W Arndt, Robert H Scannevin, Daniel Perret, Wen-Cherng Lee.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20055425     DOI： 10.1021/jm9004708

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  77 in total

1.  Alternative approaches to Hsp90 modulation for the treatment of cancer.

Authors:  Jessica A Hall; Leah K Forsberg; Brian S J Blagg
Journal:  Future Med Chem       Date:  2014-09       Impact factor: 3.808

Review 2.  Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases.

Authors:  Daniel W Neef; Alex M Jaeger; Dennis J Thiele
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

3.  Development of a Grp94 inhibitor.

Authors:  Adam S Duerfeldt; Laura B Peterson; Jason C Maynard; Chun Leung Ng; Davide Eletto; Olga Ostrovsky; Heather E Shinogle; David S Moore; Yair Argon; Christopher V Nicchitta; Brian S J Blagg
Journal:  J Am Chem Soc       Date:  2012-05-29       Impact factor: 15.419

4.  Reaction design, discovery, and development as a foundation to function-oriented synthesis.

Authors:  Glenn C Micalizio; Sarah B Hale
Journal:  Acc Chem Res       Date:  2015-02-10       Impact factor: 22.384

Review 5.  Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies.

Authors:  Yoshinari Miyata; John Koren; Janine Kiray; Chad A Dickey; Jason E Gestwicki
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

6.  Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix.

Authors:  Jason Gavenonis; Nicholas E Jonas; Joshua A Kritzer
Journal:  Bioorg Med Chem       Date:  2014-06-14       Impact factor: 3.641

7.  HSP90 is a chaperone for DLK and is required for axon injury signaling.

Authors:  Scott Karney-Grobe; Alexandra Russo; Erin Frey; Jeffrey Milbrandt; Aaron DiAntonio
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

Review 8.  Recent advances in malaria drug discovery.

Authors:  Marco A Biamonte; Jutta Wanner; Karine G Le Roch
Journal:  Bioorg Med Chem Lett       Date:  2013-03-27       Impact factor: 2.823

9.  Dynamics-Based Discovery of Allosteric Inhibitors: Selection of New Ligands for the C-terminal Domain of Hsp90.

Authors:  Giulia Morra; Marco A C Neves; Christopher J Plescia; Shinji Tsustsumi; Len Neckers; Gennady Verkhivker; Dario C Altieri; Giorgio Colombo
Journal:  J Chem Theory Comput       Date:  2010-08-30       Impact factor: 6.006

Review 10.  Probing the probes: fitness factors for small molecule tools.

Authors:  Paul Workman; Ian Collins
Journal:  Chem Biol       Date:  2010-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.